表皮生长因子对恒河猴创伤眼角膜的促恢复作用

本实验用５只恒河猴人工造成眼角膜创伤,基本一致地除去双眼角膜上皮细胞层,仅边缘部分残留有少量的角膜细胞,均以猴的右眼作实验处理,每日滴３次表皮生长因子溶液（生理盐水配制,浓度１３０μｇ／ｍｌ）;均原左眼作对照,每日仅滴３次生理盐水。每日用荧光素钠溶液滴眼,检查眼角膜创面的恢复进展情况,结果实验眼的创面在第３－４天完全恢复,对照眼则在第５－６天恢复,实验眼比对照眼约提前２－３天恢复,表明表皮生长因子     

光量子和血卟啉的放疗增敏作用与表皮生长因子关系的研究

本文采用放射免疫技术检测了充氧及充氧并用光量子或血卟啉和光量子与血卟啉联合治疗后进行局部放射治疗皮下Ｗ２５６移植瘤大鼠的血浆、瘤组织和颌下腺组织内表皮生长因子（ＥＧＦ）的含量。结果表明,与单纯充氧后放射治疗组大鼠比较：（１）光量子治疗组、血卟啉治疗组和光量子与血啉卟联合治疗组大鼠血浆ＥＧＦ含量显著升高（Ｐ〈０．０５）;（２）光量子治疗组、血卟啉治疗组和光量子与血卟啉联合治疗组大鼠组织与颌下腺中ＥＧ     

表皮生长因子对离体大鼠肺动脉及肺动脉平滑肌细胞作用的研究

本研究着重探讨表皮生长因子（ＥＧＦ）对大鼠肺动脉的收缩作用及对肺动脉平滑肌细胞分裂增殖的影响。浓度为１×１０－９－１×１０－７ｍｏｌ／Ｌ的ＥＧＦ可引起大鼠肺动脉剂量依赖性收缩（ｒ＝０．９６８,Ｐ＜０,００１）,其Ｅｍａｘ为１００．６ｍｇ,ＥＣ５０为１１．９６ｎｍｏｌ／Ｌ。在同时存在０．５％胎牛血清（ＦＣＳ）时,ＥＧＦ能促进平滑肌细胞的３Ｈ－ＴｄＲ参入率,该作用与剂量呈正相关（ｒ＝０．８２３,Ｐ＜０．０５）,其ＥＣ５０为６．５×１Ｏ－１２ｍｏｌ／Ｌ。１×１０－９ｍｏｌ／Ｌ的ＥＧＦ＋０．５％ＦＣＳ能产生与１０％ＦＣＳ相当的促细胞分裂增殖能力（在培养的第１,３,５,７天,二者促分裂增殖能力相差不明显,Ｐ均＞０．０５,第９天时,前者大于后者,Ｐ＜０．０５）。１×１０－９ｍｏｌ／ＬＥＧＦ单独存在时对平滑肌细胞未显示出明显的致分裂活性。上述作用提示ＥＣＦ在某些肺血管病变如缺氧性肺动脉高压中可能有一定意义。     

表皮生长因子对肺泡巨噬细胞趋化性的调控

采用测定趋化性的方法,观察了表皮生长因子（ＥＧＦ）和纤维连接蛋白（ＦＮ）对肺泡巨噬细胞（ＡＭ）趋化运动的影响。结果显示,ＥＧＦ能抑制ＡＭ的趋化性,量效关系显著（ｒ＝－０．９９１０,Ｐ＜０．０１）,而ＥＧＦ本身对ＡＭ并不表现趋化吸引作用。ＦＮ亦能抑制ＡＭ的趋化性（Ｐ＜０．０１）,ＥＧＦ和ＦＮ两者协同作用时,对ＡＭ趋化性的抑制程度大于各自的单独作用（Ｐ＜０．０１）。实验证明ＥＧＦ具有调节ＡＭ趋化运动的非促丝裂功能。提示肺内的细胞因子ＥＧＦ和细胞外基质成分ＦＮ参与肺部炎症及免疫反应的调控。     

大鼠皮肤切伤后成纤维细胞EGFR胶原基因表达的影响

４５只大鼠,分成７个生前损伤组,１个死后损伤组和１个正常对照组。每组５只,背部皮肤切口造创,生前伤组按伤后０、５、１０、１５、３０、６０、９０、１２０ｍｉｎ不同时间和死后在伤口缘取皮,进行切片和免疫组化实验,观察ＥＧＦＲ的基因表达。结果表明,正常和死后组不表达,生前伤组表达区沿表皮基底层和皮下组织分布,表达随时间而增强。表达率Ｐ与时间Ｔ的对数呈高度正相关（ｒ＝０．９８５）。随建立了回归方程。用回归方程计算出的表达率和时间,接近实测值。根据回归方程推导,时间是以２为底表达率为参数的指数函数。它可能提示,时间Ｔ与成纤维细胞的分裂增殖周期和数量有关。表达率作为特征参数,标志着细胞膜ＥＧＦＲ传递信息的特性。说明细胞膜ＥＧＦＲ在相互传递信息中,相互影响表达结果     

hEGF和hTGF—αN结构域与C结构域的功能差异

用ＰＣＲ的方法将人表皮生长因子和人转化生长因子－α（ｈＴＧＦ－α）的Ｎ结构域和Ｃ结构域互换,构造了两个嵌合分子Ｅ－ＴＧＦ（ＥＧＦ１－３２－ＴＧＦ－α３４－５０）和Ｔ－ＥＧＦ（ＴＧＦ－α１－３３－ＥＧＦ３３－５３）。野生型和嵌合分子基因在大肠杆菌ｐｈｏＡ系统表达并纯化定量。各重组体的受体竞争结合活性大小为ｈＥＧＦ〉ｈＴＧＦ－α和Ｅ－ＴＧＦ〉Ｔ０－ＥＧＦ,它们的促细胞生长活性的大小为ｈＴＧＦ－α和Ｅ－     

表皮生长因子对培养的气道上皮细胞抗臭氧损伤的保护作用

本研究观察到臭氧（Ｏ３）对体外培养经３Ｈ－ＵｄＲ标记的免气道上皮细胞有明显细胞毒性作用,且损伤程度与Ｏ３作用时间呈正相关。Ｏ３暴露组细胞内丙二醛（ＭＤＡ）产生增多（Ｐ＜０．０１）,提示Ｏ３损伤细胞的机制与胞膜脂质过氧化有关。表皮生长因子（ＥＧＦ）可明显降低Ｏ３所致的３Ｈ释放率（Ｐ＜０．０１）、降低Ｏ３的细胞毒指数及细胞内ＭＤＡ含量（Ｐ＜０．０１）,证明ＥＧＦ对气道上皮细胞有保护作用。进一步还观察到浓度为５ｎｇ／ｍｌ的ＥＯＦ可以取消Ｏ３所引起的细胞内还原型谷胱甘肽（ＧＳＨ）含量降低（Ｐ＜０．０１）,并增加细胞内谷胱甘肽总含量（Ｐ＜０．０５）,但不能改变Ｏ３所致的氧化型谷胱甘肽（ＧＳＳＧ）含量的增加（Ｐ＞０．０５）,对ＧＳＨ／ＧＳＳＧ比值也无明显提高,这些都提示ＥＧＦ的细胞保护机理可能与其促进细胞内谷胱甘肽合成有关,而对ＧＳＳＧ转化为ＧＳＨ的还原过程影响不明显。     

几种扩血管多肽对bFGF促血管平滑肌细胞增殖作用的影响

目的和方法：研究肾上腺髓质素（Ａｄｍ）、降钙素基因相关肽（ＣＧＲＰ）及Ｃ－型心房利太（ＣＮＰ）对碱性成纤维细胞生长因子（ｂＦＧＦ）促血管平滑细胞（ＶＳＭＣ）增殖作用的影响及其机制。结果：孵育２４ｈ后,ｂＦＧＦ刺激ＶＳＭＣ增殖较对照组增加２．１倍（Ｐ〈０．０１）,细胞内蛋白磷酸化程度增加１．４倍（Ｐ〈０．０１）,ＰＫＣ及ＭＡＰＫ活性分别增加１．５和２．５倍（Ｐ〈０．０１０;Ａｄｍ．ＣＧＲＰｔ ＣＮＰ     

颌下腺表皮生长因子促进大鼠胃粘膜损伤的愈合

用免疫组织化学方法观察到雄性大鼠颌下腺有非常丰富的表皮生长因子样免疫活性物质,并且主要位于导管细胞中,颌下腺摘除使血清尤其是胃液ＥＧＦ水平显著降低,直至手术后第２８天仍然维持在较低水平。利用颌下腺摘除术清内源性ＥＧＦ后,冰乙酸涂抹造成的慢性胃溃疡愈合速度较假手术大鼠明显减慢,而补充相应剂量的外源性ＥＧＦ可使颌下腺摘除大鼠的溃疡愈合速度恢复到与假手术组引当水平。上述结果显示,颌下腺及其分泌的ＥＧＦ对     

康复新液联合重组人表皮生长因子促进阴虚肠燥型肛裂术后创面愈合的临床观察

目的观察康复新液联合重组人表皮生长因子促进阴虚肠燥型肛裂术后创面愈合的临床效果。方法将60例阴虚肠燥型肛裂术后患者随机分为观察组和对照组各30例,两组患者均于术后第1天开始换药。对照组单纯采取重组人表皮生长因子喷洒创面换药,直至创面痊愈;观察组术后采取康复新液纱条填塞创面联合重组人表皮生长因子喷洒创面换药。比较两组患者的创面愈合时间及治疗效果。结果观察组的创面愈合时间为(26.28±2.81)天,对照组为(34.40±3.45)天,观察组的创面愈合时间明显短于对照组,差异具有统计学意义(P0.05)。两组治愈率比较,观察组为76.7%高于对照组的40.0%,两组比较差异具有统计学意义(P0.05)。结论康复新液纱条填塞创面联合重组人表皮生长因子喷洒创面换药可有效促进阴虚肠燥型肛裂术后创面愈合,提高治疗效果。     

The effect of EGF application in gel form on histamine content of experimentally induced wound in mice

Summary. The factors participating to the wound healing are complex and still obscure. Among these factors, epidermal growth factor (EGF) and histamine by increasing reepithelization and reparation tissue strength via enhancing collagen deposition to the wound site have a beneficial effect. This study was performed to investigate the effect of EGF dosage forms on the histamine content of the experimentally induced wound and some wound healing criters in the mice.Histological investigation of reepithelization, wound tensile strength for healing and collagen maturation, and histamine levels were assessed in the present study. Thirty two mice were divided into control, and EGF treated groups. Controls included three subgroups; untreated (n=5), 0.9% NaCl applied (n=5), and gel applied (n=5). Experimental groups were treated with two forms of EGF; EGF, solution form in 0.9% NaCl (n=5) and the gel form in 0.2% w/w in carbopol 940 (n=7). The discrepancy between these forms were evaluated. This evaluation was done by the application of two forms of EGF for 15 days on experimentally induced wound healing.Gel form of EGF by sustained release from bioadhesive polymer is found to be more effective than the soluble form, on the healing of the wound, by acceleration of reepithelization and increment of wound tensile strength. The tensile strength of the wound indicates the rate of repair and collagen maturation. It has been observed that when physiological saline and carbopol 940 exposed to incision without EGF causes a significant increase in tissue histamine content.According to the results of the present investigation; the histamine content is found to be decreased by EGF gel dosage form treatment, therefore preventing abnormal collagen formation has a beneficial effect on wound healing.     

Effects of topical applications of epidermal growth factor on wound healing. Experimental study on rabbit ears

In wounds in rabbit ears, the application every 12 hours of an ointment containing epidermal growth factor appears to produce faster and better healing. The resulting epithelium is thicker and more cellular than in the untreated ear wounds, and more fibroblasts appeared sooner during the healing process. Less wound contracture occurred in the EFG-treated wounds, and wound maturation occurred earlier. The healed wounds that had been treated with EGF more closely resembled the surrounding normal tissue, producing less local deformity than in the controls. It is too early to know whether this will have clinical application, but other experiments are under way to further investigate the effects of EGF on wound healing.     

EGF and TGF-alpha in wound healing and repair

Wound healing is a localized process which involves inflammation, wound cell migration and mitosis, neovascularization, and regeneration of the extracellular matrix. Recent data suggest the actions of wound cells may be regulated by local production of peptide growth factors which influence wound cells through autocrine and paracrine mechanisms. Two peptide growth factors which may play important roles in normal wound healing in tissues such as skin, cornea, and gastrointestinal tract are the structurally related peptides epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). EGF/TGF-alpha receptors are expressed by many types of cells including skin keratinocytes, fibroblasts, vascular endothelial cells, and epithelial cells of the GI tract. In addition, EGF or TGF-alpha are synthesized by several cells involved in wound healing including platelets, keratinocytes, and activated macrophages. Healing of a variety of wounds in animals and patients was enhanced by treatment with EGF or TGF-alpha. Epidermal regeneration of partial thickness burns on pigs or dermatome wounds on patients was accelerated with topical application of EGF or TGF-alpha, and EGF treatment accelerated healing of gastroduodenal ulcers. EGF also increased tensile strength of skin incisions in rats and corneal incisions in rabbits, cats, and primates. Additional research is needed to better define the roles of EGF, TGF-alpha and their receptor in normal wound healing, to determine if alterations have occurred in the EGF/TGF-alpha system in chronic wounds, and optimize vehicles for effective delivery of peptide growth factors to wounds.     

Stimulation of growth factor synthesis in skin wounds using tissue extract (G-90) from the earthworm Eissenia foetida

Growth factors are biologically-active mediators that bind to specific receptors on target cells and regulate genes involved in cell growth, wound healing and regeneration. In the case of wound healing, a proper wound dressing is needed to cover the wound area, protect the damaged tissue, and if possible to activate cell proliferation and stimulate the healing process. In this study we examined the efficacy of a glycolipoprotein tissue homogenate extract from Eisenia foetida (G-90) to activate signal transduction pathways, leading to wound healing. We measured the activation of EGF and FGF in healthy skin, in wounds with physiological healing and in wounds treated with G-90. The activation of EGF and FGF was measured during the first 24 h of wound healing under both physiological conditions and treatment with G-90. In both cases an increased concentration of EGF and FGF was observed 6 h after wounding. In comparison with healthy skin, the concentration of EGF increased 10-fold and FGF five-fold in wounds treated with G-90 (10 ng ml(-1)). Healing in physiological conditions resulted in a two-fold increase of EGF and 1.5-fold of FGF.     

Basement membrane formation during wound healing is dependent on epidermal transplants

The purpose of the study was to compare directly the effect of healing and the formation of the basement membrane during wound healing from two autologous primary keratinocyte cultures in the liquid environment in full-thickness wounds in pigs. Wounds were either transplanted with cultured epidermal autografts (n = 26) or autologous keratinocyte suspensions (n = 24) or treated with saline alone (n = 40) and covered with a chamber. All wounds transplanted with cultured epidermal autografts and keratinocyte cell suspensions had positive "take" after transplantation. Healing times were significantly shorter for wounds treated with either cultured epidermal autografts or keratinocyte suspensions (p = 0.0001) compared with saline-treated wounds but were not different from each other (p = 0.1835). There were no differences in cytokeratin and laminin expression; however, staining with monoclonal antibody against collagen type VII showed a lower signal for cultured epidermal autografts only on days 8 and 16 compared with keratinocyte suspensions. Electron microscope evaluation showed a higher incidence of anchoring fibrils and a more mature dermal-epidermal junction in wounds treated with keratinocyte cell suspensions at day 8. These findings may be due to the single, noncontact-inhibited cells and the early formation of an in vivo neodermis to the wet wound environment. These data suggest that wounds transplanted with autologous keratinocyte suspensions in a wet environment may be an alternative method in the treatment of wounds.     

Angiogenesis Is Induced and Wound Size Is Reduced by Electrical Stimulation in an Acute Wound Healing Model in Human Skin

Angiogenesis is critical for wound healing. Insufficient angiogenesis can result in impaired wound healing and chronic wound formation. Electrical stimulation (ES) has been shown to enhance angiogenesis. We previously showed that ES enhanced angiogenesis in acute wounds at one time point (day 14). The aim of this study was to further evaluate the role of ES in affecting angiogenesis during the acute phase of cutaneous wound healing over multiple time points. We compared the angiogenic response to wounding in 40 healthy volunteers (divided into two groups and randomised), treated with ES (post-ES) and compared them to secondary intention wound healing (control). Biopsy time points monitored were days 0, 3, 7, 10, 14. Objective non-invasive measures and H&E analysis were performed in addition to immunohistochemistry (IHC) and Western blotting (WB). Wound volume was significantly reduced on D7, 10 and 14 post-ES (p = 0.003, p = 0.002, p<0.001 respectively), surface area was reduced on days 10 (p = 0.001) and 14 (p<0.001) and wound diameter reduced on days 10 (p = 0.009) and 14 (p = 0.002). Blood flow increased significantly post-ES on D10 (p = 0.002) and 14 (p = 0.001). Angiogenic markers were up-regulated following ES application; protein analysis by IHC showed an increase (p<0.05) in VEGF-A expression by ES treatment on days 7, 10 and 14 (39%, 27% and 35% respectively) and PLGF expression on days 3 and 7 (40% on both days), compared to normal healing. Similarly, WB demonstrated an increase (p<0.05) in PLGF on days 7 and 14 (51% and 35% respectively). WB studies showed a significant increase of 30% (p>0.05) on day 14 in VEGF-A expression post-ES compared to controls. Furthermore, organisation of granulation tissue was improved on day 14 post-ES. This randomised controlled trial has shown that ES enhanced wound healing by reduced wound dimensions and increased VEGF-A and PLGF expression in acute cutaneous wounds, which further substantiates the role of ES in up-regulating angiogenesis as observed over multiple time points. This therapeutic approach may have potential application for clinical management of delayed and chronic wounds.     

Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition.

Fetal wounds pass from scarless repair to healing with scar formation during gestation. This transition depends on both the size of the wound and the gestational age of the fetus. This study defines the transition period in the fetal rat model and provides new insight into scarless collagen wound architecture by using confocal microscopy. A total of 16 pregnant Sprague-Dawley rats were operated on. Open full-thickness wounds, 2 mm in diameter, were created on fetal rats at gestational ages 14.5 days (E14; n = 10), 16.5 days (E16; n = 42), and 18.5 days (E18; n = 42) (term = 21.5 days). Wounds were harvested at 24 (n = 18 per gestational age) and 72 hours (n = 24 per gestational age). Skin at identical gestational ages to wound harvest was used for controls. The wounds were fixed and stained with hematoxylin and eosin, antibody to type I collagen, and Sirius red for confocal microscopic evaluation. No E14 rat fetuses survived to wound harvest. Wounds created on E16 fetal rats healed completely and without scarring. E16 fetal rat hair follicle formation and collagen architecture was similar to that of normal, nonwounded skin. Wounds created on E18 fetal rats demonstrated slower healing; only 50 percent were completely healed at 72 hours compared with 100 percent of the E16 fetal rat wounds at 72 hours. Furthermore, the E18 wounds healed with collagen scar formation and without hair follicle formation. Confocal microscopy demonstrated that the collagen fibers were thin and arranged in a wispy pattern in E16 fetal rat wounds and in nonwounded dermis. E18 fetal rat wounds had thickened collagen fibers with large interfiber distances. Two-millimeter excisional E16 fetal rat wounds heal without scar formation and with regeneration of normal dermal and epidermal appendage architecture. E18 fetal rat wounds heal in a pattern similar to that of adult cutaneous wounds, with scar formation and absence of epidermal appendages. Confocal microscopy more clearly defined the dermal architecture in normal skin, scarless wounds, and scars. These data further define the transition period in the fetal rat wound model, which promises to be an effective system for the study of in vivo scarless wound healing.     

创伤合并海水浸泡后愈合过程的病理学观察

目的观察创伤合并海水浸泡后对伤口愈合时间的影响及愈合过程中的病理学改变。方法以大鼠为实验动物,建立背部双侧圆形创伤模型,创后随机分为对照组和实验组,每组50只,实验组创后置海水中浸泡30min。观察2组创面的愈合生长状况。观察伤口局部愈合过程中的病理学改变,应用免疫组化方法观察愈合过程中伤口修复细胞增殖指数及微血管密度变化。结果对照组平均愈合时间为（12.0±1.0）d,而实验组的平均愈合时间为（14.3±0.8）d;两组在肉芽组织形成时间上以及修复细胞增殖能力上存在差异。结论创伤合并海水浸泡可导致伤口愈合时间延迟,加重创伤局部的炎症反应、延缓肉芽组织形成时间。     

Advanced glycation end products delay corneal epithelial wound healing through reactive oxygen species generation

Delayed healing of corneal epithelial wounds is a serious complication in diabetes. Advanced glycation end products (AGEs) are intimately associated with the diabetic complications and are deleterious to the wound healing process. However, the effect of AGEs on corneal epithelial wound healing has not yet been evaluated. In the present study, we investigated the effect of AGE-modified bovine serum albumin (BSA) on corneal epithelial wound healing and its underlying mechanisms. Our data showed that AGE-BSA significantly increased the generation of intracellular ROS in telomerase-immortalized human corneal epithelial cells. However, the generation of intracellular ROS was completely inhibited by antioxidant N-acetylcysteine (NAC), anti-receptor of AGEs (RAGE) antibodies, or the inhibitor of NADPH oxidase. Moreover, AGE-BSA increased NADPH oxidase activity and protein expression of NADPH oxidase subunits, p22phox and Nox4, but anti-RAGE antibodies eliminated these effects. Furthermore, prevention of intracellular ROS generation using NAC or anti-RAGE antibodies rescued AGE-BSA-delayed epithelial wound healing in porcine corneal organ culture. In conclusion, our results demonstrated that AGE-BSA impaired corneal epithelial wound healing ex vivo. AGE-BSA increased intracellular ROS generation through NADPH oxidase activation, which accounted for the delayed corneal epithelial wound healing. These results may provide better insights for understanding the mechanism of delayed healing of corneal epithelial wounds in diabetes.